The EnteroMedics (ETRM) Given Daily News Sentiment Rating of 0.31

The EnteroMedics (ETRM) Given Daily News Sentiment Rating of 0.31

These are some of the headlines that may have effected AlphaOne’s scoring:

Media coverage about EnteroMedics (NASDAQ:ETRM) has trended positive on Monday, according to Alpha One Sentiment Analysis. The research firm, a service of Accern, scores the sentiment of news coverage by analyzing more than twenty million blog and news sources. Alpha One ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. EnteroMedics earned a news sentiment score of 0.31 on Alpha One’s scale. Alpha One also gave news headlines about the medical device company an impact score of 100 out of 100, meaning that recent news coverage is extremely likely to have an impact on the company’s share price in the near future.

Separately, Ladenburg Thalmann Financial Services started coverage on shares of EnteroMedics in a research note on Wednesday, May 3rd. They set a “buy” rating and a $11.00 target price for the company. Shares of EnteroMedics (NASDAQ:ETRM) opened at 5.15 on Monday. EnteroMedics has a 1-year low of $0.04 and a 1-year high of $30.41. The stock’s market capitalization is $35.57 million. The company has a 50-day moving average of $4.73 and a 200-day moving average of $4.97.

EnteroMedics Company Profile EnteroMedics Inc (EnteroMedics) is a medical device company. The Company is focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. The Company’s neuroblocking technology, which is referred to as VBLOC therapy, is designed to intermittently block the vagus nerve.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:ETRM”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for EnteroMedics Inc Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for EnteroMedics Inc and related companies with MarketBeat.com’s FREE daily email newsletter.

Related posts

Leave a Comment